Statistics

Total Visits

Views
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.85

Select a period of time:

Number of views in the range

Views
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.15

Views

Views
September 20254
October 20253
November 20251
December 20253
January 20260
February 20260
March 20264
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil4
Morocco2
United States2
United Kingdom2
Argentina1
Chile1
Colombia1
Kenya1
Nicaragua1
 

Top cities views

Views
Ashburn1
Barcarena Nova1
Casablanca1
Concepción1
Dallas1
Managua1
Medellín1
Moreno1
Nairobi1
Piracicaba1